Oxigene Inc (NASDAQ:OXGN)

zzlangerhans (99.79) Submitted: 10/9/2012 10:29:49 PM : Start Price: $6.38 OXGN Score: -61.83

This is a Hail Mary pick that I'd compare to my Peregrine pick of a few months ago. That one worked out pretty well, so let's see how this goes. I have no idea where the miracle, if any, is going to come from but Peregrine's seemed to materialize out of nothing as well. Oxigene doesn't even have any trials in progress that I'm aware of, just an SPA for a pointless trial of a failed drug and no funds to run the trial. As you may have guessed, I'm not really buying this stock.

BACnumber1 (< 20) Submitted: 11/9/2011 4:13:45 AM : Start Price: $13.68 OXGN Score: +108.28

Sadly I own this company.....

BamaBoyT (77.98) Submitted: 9/15/2011 9:35:05 AM : Start Price: $16.44 OXGN Score: -117.45

This will be a hot stock to day trade. Will be around 5 dollars in near future.

kanol (< 20) Submitted: 5/11/2011 10:00:19 AM : Start Price: $54.34 OXGN Score: -116.25

UP UP UP EXPLOSION!

kampaakampaa (< 20) Submitted: 6/17/2010 9:51:02 AM : Start Price: $141.58 OXGN Score: +145.24

New financing and need more Falcon data

armyinu (< 20) Submitted: 6/1/2009 2:40:50 PM : Start Price: $564.00 OXGN Score: -175.65

I see it that this drud is going to finish ahead and that the FDA will aprove it and this stock is going to sky rocket if i where you I would buy buy buy

suave1007 (< 20) Submitted: 8/14/2007 6:29:40 PM : Start Price: $856.80 OXGN Score: -121.65

Science: Destroys in minutes ALL blood vessels of tumor!while preserving ALL other healthy cells!! NO side effects:
http://www.wsw.com/webcast/rrshq10/oxgn/3__Slide16.JPG
OXGN SAFETY:Lazard pres.

Seasoned and creditentialled Mgt Team under Dr. Richard Chin who guided two of Genentechs current blockbusters: Avastin & Lucentis. In his 3rd month as CEO downsized co 33% and focused strategy of timely executions.

Poised for Success is OXGN's Mantra.

$4+mln of open mkt purchases by mgt team! $65K during Aug 5-10 by newest director Fickling.

Indeed rare to find a $100 mln Mkt Cap. oncology play IN Phase THREE!

jwfoster (31.44) Submitted: 5/5/2007 10:34:23 PM : Start Price: $1,137.60 OXGN Score: -117.60

I am not smart enough to figure out which drugs will be good or bad. What will pass phase III trials, etc. But, what I do know is that when a biotech stock has tons of insiders who know the drug business buying up shares like crazy and have a lung cancer product that they can charge whatever they would want, it is worthy of buying.

This is not just a caps pick but, one of my larger personal holdings.

oj1480 (< 20) Submitted: 2/5/2007 10:50:03 AM : Start Price: $1,063.20 OXGN Score: -121.06

i heard good news about this one.

TechnicalTommy (67.77) Submitted: 1/17/2007 4:29:07 AM : Start Price: $1,130.40 OXGN Score: -122.64

Favorable news from pipeline in December. Things have finally settled down now.

alyssakh (< 20) Submitted: 11/25/2006 9:48:23 PM : Start Price: $1,080.00 OXGN Score: -124.95

Clinical trials almost done.